glp-1 weight loss drug news today 2025 Weight-Loss Drugs Could Address a Range of Addictions Americans turn to risky unregulated

In recent years, the gut-brain axis has been increasingly considered a promising topic for the study of CNS-related diseases because the gut microbiota and gut hormones have been shown to interact with other organs including the brain (Knight et al., 2017), although the mechanisms involved in gut homeostasis and brain function are as yet uncharacterized (Neufeld and Foster, 2009)

Argun-Kurum G, Kaya-Dagistanli F, Ozturk M

In a paradoxical fashion, postprandial hyperglucagonemia a common finding in T2DM contributes to glucose excursions in the fed state

A threat to independent pharmacies in the USA Independent pharmacists in the US are stopping the sale of diabetes drug Ozempic because they are being underpaid by pharmacy benefits managers, according to a report by NBC

GLP-1 therapy, by promoting significant weight loss, tackles the main risk factor: fat accumulation around the airway

The formulary will list which tier Trulicity falls under